It is, therefore, essential to look into the numerous pathways in which nesfatin-1 levels may be altered in different obesity phenotypes to shed light on the complex nature of this hormone’s role in metabolism and its therapeutic potential. Here, NUCB2 is linked to obesity due to melanocortin 4 receptor deficiency.